nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—thyroid cancer	0.728	1	CbGaD
Bezafibrate—CYP2C8—Sorafenib—thyroid cancer	0.00784	0.43	CbGbCtD
Bezafibrate—CYP3A4—Vandetanib—thyroid cancer	0.00528	0.289	CbGbCtD
Bezafibrate—Serum creatinine increased—Vandetanib—thyroid cancer	0.00413	0.0419	CcSEcCtD
Bezafibrate—Cholelithiasis—Vandetanib—thyroid cancer	0.00408	0.0414	CcSEcCtD
Bezafibrate—PPARA—neck—thyroid cancer	0.00394	0.129	CbGeAlD
Bezafibrate—CYP3A4—Sorafenib—thyroid cancer	0.00318	0.174	CbGbCtD
Bezafibrate—HMGCR—neck—thyroid cancer	0.00263	0.0855	CbGeAlD
Bezafibrate—PPARD—thyroid gland—thyroid cancer	0.0022	0.0718	CbGeAlD
Bezafibrate—PPARG—neck—thyroid cancer	0.00217	0.0707	CbGeAlD
Bezafibrate—HMGCR—saliva-secreting gland—thyroid cancer	0.00205	0.0667	CbGeAlD
Bezafibrate—Balsalazide—PPARG—thyroid cancer	0.00203	0.488	CrCbGaD
Bezafibrate—PPARD—head—thyroid cancer	0.00195	0.0637	CbGeAlD
Bezafibrate—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00194	0.0196	CcSEcCtD
Bezafibrate—CYP3A4—Doxorubicin—thyroid cancer	0.00193	0.106	CbGbCtD
Bezafibrate—PPARA—thyroid gland—thyroid cancer	0.00188	0.0612	CbGeAlD
Bezafibrate—Blood creatinine increased—Vandetanib—thyroid cancer	0.00173	0.0175	CcSEcCtD
Bezafibrate—PPARA—head—thyroid cancer	0.00167	0.0543	CbGeAlD
Bezafibrate—Gastritis—Vandetanib—thyroid cancer	0.00163	0.0165	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00163	0.0165	CcSEcCtD
Bezafibrate—Influenza—Vandetanib—thyroid cancer	0.00159	0.0162	CcSEcCtD
Bezafibrate—HMGCR—trachea—thyroid cancer	0.00158	0.0515	CbGeAlD
Bezafibrate—Bronchitis—Vandetanib—thyroid cancer	0.00153	0.0155	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00145	0.0147	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00141	0.0143	CcSEcCtD
Bezafibrate—Eczema—Sorafenib—thyroid cancer	0.00138	0.014	CcSEcCtD
Bezafibrate—PPARD—lymph node—thyroid cancer	0.00137	0.0446	CbGeAlD
Bezafibrate—Renal failure acute—Sorafenib—thyroid cancer	0.00135	0.0137	CcSEcCtD
Bezafibrate—Myositis—Epirubicin—thyroid cancer	0.00129	0.0131	CcSEcCtD
Bezafibrate—Urinary tract disorder—Vandetanib—thyroid cancer	0.00126	0.0128	CcSEcCtD
Bezafibrate—Urethral disorder—Vandetanib—thyroid cancer	0.00125	0.0127	CcSEcCtD
Bezafibrate—HMGCR—thyroid gland—thyroid cancer	0.00125	0.0407	CbGeAlD
Bezafibrate—Erythema multiforme—Vandetanib—thyroid cancer	0.00121	0.0122	CcSEcCtD
Bezafibrate—Myositis—Doxorubicin—thyroid cancer	0.00119	0.0121	CcSEcCtD
Bezafibrate—PPARA—lymph node—thyroid cancer	0.00117	0.038	CbGeAlD
Bezafibrate—Alopecia—Vandetanib—thyroid cancer	0.00113	0.0114	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00112	0.0114	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00112	0.0114	CcSEcCtD
Bezafibrate—HMGCR—head—thyroid cancer	0.00111	0.0361	CbGeAlD
Bezafibrate—Gastritis—Sorafenib—thyroid cancer	0.0011	0.0112	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.0011	0.0111	CcSEcCtD
Bezafibrate—Muscle spasms—Vandetanib—thyroid cancer	0.00107	0.0108	CcSEcCtD
Bezafibrate—Transaminases increased—Epirubicin—thyroid cancer	0.00104	0.0105	CcSEcCtD
Bezafibrate—PPARG—thyroid gland—thyroid cancer	0.00103	0.0336	CbGeAlD
Bezafibrate—Serum creatinine increased—Epirubicin—thyroid cancer	0.00103	0.0104	CcSEcCtD
Bezafibrate—Erectile dysfunction—Sorafenib—thyroid cancer	0.00099	0.01	CcSEcCtD
Bezafibrate—Transaminases increased—Doxorubicin—thyroid cancer	0.000963	0.00976	CcSEcCtD
Bezafibrate—Serum creatinine increased—Doxorubicin—thyroid cancer	0.000952	0.00965	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00095	0.00963	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000945	0.00958	CcSEcCtD
Bezafibrate—Myocardial infarction—Sorafenib—thyroid cancer	0.000939	0.00952	CcSEcCtD
Bezafibrate—PPARG—head—thyroid cancer	0.000916	0.0298	CbGeAlD
Bezafibrate—Infection—Vandetanib—thyroid cancer	0.0009	0.00912	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—thyroid cancer	0.000897	0.215	CrCbGaD
Bezafibrate—Thrombocytopenia—Vandetanib—thyroid cancer	0.000887	0.00899	CcSEcCtD
Bezafibrate—Balsalazide—PTGS2—thyroid cancer	0.000859	0.206	CrCbGaD
Bezafibrate—Urinary tract disorder—Sorafenib—thyroid cancer	0.00085	0.00861	CcSEcCtD
Bezafibrate—Urethral disorder—Sorafenib—thyroid cancer	0.000843	0.00855	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000825	0.00837	CcSEcCtD
Bezafibrate—Insomnia—Vandetanib—thyroid cancer	0.00082	0.00831	CcSEcCtD
Bezafibrate—Erythema multiforme—Sorafenib—thyroid cancer	0.000813	0.00825	CcSEcCtD
Bezafibrate—Dyspepsia—Vandetanib—thyroid cancer	0.000798	0.00808	CcSEcCtD
Bezafibrate—CYP1A1—trachea—thyroid cancer	0.000794	0.0259	CbGeAlD
Bezafibrate—HMGCR—lymph node—thyroid cancer	0.000776	0.0253	CbGeAlD
Bezafibrate—Constipation—Vandetanib—thyroid cancer	0.000775	0.00785	CcSEcCtD
Bezafibrate—Pain—Vandetanib—thyroid cancer	0.000775	0.00785	CcSEcCtD
Bezafibrate—Alopecia—Sorafenib—thyroid cancer	0.00076	0.00771	CcSEcCtD
Bezafibrate—Erythema—Sorafenib—thyroid cancer	0.000749	0.00759	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000741	0.00751	CcSEcCtD
Bezafibrate—Muscle spasms—Sorafenib—thyroid cancer	0.00072	0.0073	CcSEcCtD
Bezafibrate—Abdominal pain—Vandetanib—thyroid cancer	0.000716	0.00726	CcSEcCtD
Bezafibrate—Anaemia—Sorafenib—thyroid cancer	0.000692	0.00702	CcSEcCtD
Bezafibrate—PPARG—lymph node—thyroid cancer	0.000641	0.0209	CbGeAlD
Bezafibrate—Pruritus—Vandetanib—thyroid cancer	0.000641	0.0065	CcSEcCtD
Bezafibrate—Myalgia—Sorafenib—thyroid cancer	0.000638	0.00646	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000633	0.00642	CcSEcCtD
Bezafibrate—CYP1A1—thyroid gland—thyroid cancer	0.000628	0.0205	CbGeAlD
Bezafibrate—Diarrhoea—Vandetanib—thyroid cancer	0.00062	0.00628	CcSEcCtD
Bezafibrate—Infection—Sorafenib—thyroid cancer	0.000607	0.00616	CcSEcCtD
Bezafibrate—Dizziness—Vandetanib—thyroid cancer	0.000599	0.00607	CcSEcCtD
Bezafibrate—Thrombocytopenia—Sorafenib—thyroid cancer	0.000598	0.00607	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000586	0.00594	CcSEcCtD
Bezafibrate—Rash—Vandetanib—thyroid cancer	0.000571	0.00579	CcSEcCtD
Bezafibrate—Dermatitis—Vandetanib—thyroid cancer	0.000571	0.00579	CcSEcCtD
Bezafibrate—Headache—Vandetanib—thyroid cancer	0.000568	0.00575	CcSEcCtD
Bezafibrate—CYP1A1—head—thyroid cancer	0.000557	0.0182	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000557	0.00564	CcSEcCtD
Bezafibrate—Nausea—Vandetanib—thyroid cancer	0.000538	0.00546	CcSEcCtD
Bezafibrate—Dyspepsia—Sorafenib—thyroid cancer	0.000538	0.00545	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000528	0.00536	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—thyroid cancer	0.000523	0.00531	CcSEcCtD
Bezafibrate—Constipation—Sorafenib—thyroid cancer	0.000523	0.0053	CcSEcCtD
Bezafibrate—Pain—Sorafenib—thyroid cancer	0.000523	0.0053	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—thyroid cancer	0.000514	0.00521	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—thyroid cancer	0.000511	0.00518	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0005	0.00507	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—thyroid cancer	0.000498	0.00505	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000489	0.00496	CcSEcCtD
Bezafibrate—Urticaria—Sorafenib—thyroid cancer	0.000486	0.00492	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—thyroid cancer	0.000484	0.00491	CcSEcCtD
Bezafibrate—Abdominal pain—Sorafenib—thyroid cancer	0.000483	0.0049	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—thyroid cancer	0.000477	0.00483	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—thyroid cancer	0.000475	0.00482	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—thyroid cancer	0.000473	0.0048	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—thyroid cancer	0.000461	0.00467	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—thyroid cancer	0.000452	0.00459	CcSEcCtD
Bezafibrate—Hypersensitivity—Sorafenib—thyroid cancer	0.00045	0.00456	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—thyroid cancer	0.000441	0.00447	CcSEcCtD
Bezafibrate—Pruritus—Sorafenib—thyroid cancer	0.000432	0.00438	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—thyroid cancer	0.000431	0.00436	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—thyroid cancer	0.000424	0.0043	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—thyroid cancer	0.000419	0.00424	CcSEcCtD
Bezafibrate—Diarrhoea—Sorafenib—thyroid cancer	0.000418	0.00424	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000414	0.0042	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000414	0.0042	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—thyroid cancer	0.000407	0.00412	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000405	0.00411	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—thyroid cancer	0.000405	0.00411	CcSEcCtD
Bezafibrate—Dizziness—Sorafenib—thyroid cancer	0.000404	0.0041	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000398	0.00404	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—thyroid cancer	0.000397	0.00403	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000393	0.00398	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—thyroid cancer	0.00039	0.0127	CbGeAlD
Bezafibrate—Rash—Sorafenib—thyroid cancer	0.000385	0.00391	CcSEcCtD
Bezafibrate—Dermatitis—Sorafenib—thyroid cancer	0.000385	0.0039	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000383	0.00388	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000383	0.00388	CcSEcCtD
Bezafibrate—Headache—Sorafenib—thyroid cancer	0.000383	0.00388	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—thyroid cancer	0.000382	0.00387	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—thyroid cancer	0.000379	0.0908	CrCbGaD
Bezafibrate—Pancytopenia—Epirubicin—thyroid cancer	0.000377	0.00382	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—thyroid cancer	0.000376	0.00381	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—thyroid cancer	0.000375	0.0038	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000375	0.0038	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—thyroid cancer	0.000368	0.00373	CcSEcCtD
Bezafibrate—PPARA—Organelle biogenesis and maintenance—RXRA—thyroid cancer	0.000366	0.00304	CbGpPWpGaD
Bezafibrate—Nausea—Sorafenib—thyroid cancer	0.000363	0.00368	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000363	0.00368	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—thyroid cancer	0.000353	0.00358	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000351	0.00356	CcSEcCtD
Bezafibrate—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000351	0.00291	CbGpPWpGaD
Bezafibrate—Pancytopenia—Doxorubicin—thyroid cancer	0.000349	0.00354	CcSEcCtD
Bezafibrate—PPARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000343	0.00285	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00034	0.00283	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000339	0.00282	CbGpPWpGaD
Bezafibrate—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000337	0.0028	CbGpPWpGaD
Bezafibrate—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000335	0.0034	CcSEcCtD
Bezafibrate—PPARD—Adipogenesis—PPARG—thyroid cancer	0.000331	0.00275	CbGpPWpGaD
Bezafibrate—PPARG—PPARA activates gene expression—RXRA—thyroid cancer	0.000327	0.00272	CbGpPWpGaD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000325	0.00329	CcSEcCtD
Bezafibrate—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000324	0.00269	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.00032	0.00266	CbGpPWpGaD
Bezafibrate—Pharyngitis—Epirubicin—thyroid cancer	0.000316	0.0032	CcSEcCtD
Bezafibrate—HMGCR—PPARA activates gene expression—PPARG—thyroid cancer	0.000315	0.00262	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Epirubicin—thyroid cancer	0.000314	0.00318	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—thyroid cancer	0.000312	0.00316	CcSEcCtD
Bezafibrate—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000308	0.00256	CbGpPWpGaD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000308	0.00256	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MINPP1—thyroid cancer	0.000308	0.00256	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—thyroid cancer	0.000305	0.00254	CbGpPWpGaD
Bezafibrate—HMGCR—TOR Signaling—AKT1—thyroid cancer	0.000305	0.00253	CbGpPWpGaD
Bezafibrate—Erythema multiforme—Epirubicin—thyroid cancer	0.000301	0.00305	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—TRIM33—thyroid cancer	0.0003	0.00249	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—HIF1A—thyroid cancer	0.000297	0.00246	CbGpPWpGaD
Bezafibrate—Pharyngitis—Doxorubicin—thyroid cancer	0.000292	0.00296	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000291	0.00294	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—thyroid cancer	0.000288	0.00292	CcSEcCtD
Bezafibrate—PPARA—PPARA activates gene expression—PPARG—thyroid cancer	0.000288	0.0024	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—RXRA—thyroid cancer	0.000286	0.00238	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MEN1—thyroid cancer	0.000286	0.00238	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—thyroid cancer	0.000286	0.00237	CbGpPWpGaD
Bezafibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000282	0.00234	CbGpPWpGaD
Bezafibrate—Alopecia—Epirubicin—thyroid cancer	0.000281	0.00285	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—thyroid cancer	0.000278	0.00282	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—thyroid cancer	0.000277	0.00281	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—thyroid cancer	0.000273	0.00276	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CCND1—thyroid cancer	0.000267	0.00222	CbGpPWpGaD
Bezafibrate—Muscle spasms—Epirubicin—thyroid cancer	0.000266	0.0027	CcSEcCtD
Bezafibrate—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000262	0.00218	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—NDUFA13—thyroid cancer	0.000262	0.00218	CbGpPWpGaD
Bezafibrate—Alopecia—Doxorubicin—thyroid cancer	0.00026	0.00264	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—MINPP1—thyroid cancer	0.000256	0.00213	CbGpPWpGaD
Bezafibrate—Erythema—Doxorubicin—thyroid cancer	0.000256	0.0026	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—thyroid cancer	0.000256	0.00259	CcSEcCtD
Bezafibrate—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000255	0.00212	CbGpPWpGaD
Bezafibrate—Flatulence—Doxorubicin—thyroid cancer	0.000252	0.00256	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—PPARG—thyroid cancer	0.000252	0.0021	CbGpPWpGaD
Bezafibrate—Muscle spasms—Doxorubicin—thyroid cancer	0.000246	0.0025	CcSEcCtD
Bezafibrate—PPARD—Metabolism—CHST14—thyroid cancer	0.000246	0.00205	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000246	0.00204	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000243	0.00202	CbGpPWpGaD
Bezafibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00024	0.002	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000238	0.00198	CbGpPWpGaD
Bezafibrate—Anaemia—Doxorubicin—thyroid cancer	0.000237	0.0024	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—thyroid cancer	0.000236	0.00239	CcSEcCtD
Bezafibrate—PPARA—Metabolism—MINPP1—thyroid cancer	0.000235	0.00195	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—TRIM33—thyroid cancer	0.000229	0.0019	CbGpPWpGaD
Bezafibrate—Infection—Epirubicin—thyroid cancer	0.000224	0.00227	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—thyroid cancer	0.000221	0.00224	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000221	0.00184	CbGpPWpGaD
Bezafibrate—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000221	0.00183	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NDUFA13—thyroid cancer	0.000218	0.00181	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000218	0.00181	CbGpPWpGaD
Bezafibrate—Myalgia—Doxorubicin—thyroid cancer	0.000218	0.00221	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—THRB—thyroid cancer	0.000217	0.0018	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—thyroid cancer	0.000214	0.00178	CbGpPWpGaD
Bezafibrate—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000213	0.00177	CbGpPWpGaD
Bezafibrate—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000213	0.00177	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—HIF1A—thyroid cancer	0.000213	0.00177	CbGpPWpGaD
Bezafibrate—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000213	0.00177	CbGpPWpGaD
Bezafibrate—Infection—Doxorubicin—thyroid cancer	0.000208	0.0021	CcSEcCtD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000206	0.00171	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000206	0.00171	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000206	0.00209	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—CHST14—thyroid cancer	0.000205	0.0017	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000205	0.00207	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—thyroid cancer	0.000204	0.00207	CcSEcCtD
Bezafibrate—PPARA—Metabolism—NDUFA13—thyroid cancer	0.000199	0.00166	CbGpPWpGaD
Bezafibrate—Dyspepsia—Epirubicin—thyroid cancer	0.000199	0.00202	CcSEcCtD
Bezafibrate—PPARD—Metabolism—HPGD—thyroid cancer	0.000198	0.00165	CbGpPWpGaD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000195	0.00162	CbGpPWpGaD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000194	0.00162	CbGpPWpGaD
Bezafibrate—Constipation—Epirubicin—thyroid cancer	0.000193	0.00196	CcSEcCtD
Bezafibrate—Pain—Epirubicin—thyroid cancer	0.000193	0.00196	CcSEcCtD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000192	0.00159	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—RXRA—thyroid cancer	0.000191	0.00159	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00019	0.00193	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—thyroid cancer	0.000189	0.00192	CcSEcCtD
Bezafibrate—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000188	0.00156	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—thyroid cancer	0.000188	0.00156	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CHST14—thyroid cancer	0.000188	0.00156	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000185	0.00154	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—CP—thyroid cancer	0.000185	0.00154	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000185	0.00187	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—thyroid cancer	0.000184	0.00186	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000182	0.00152	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—AKT1—thyroid cancer	0.000181	0.0015	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—AKT1—thyroid cancer	0.000181	0.0015	CbGpPWpGaD
Bezafibrate—Urticaria—Epirubicin—thyroid cancer	0.000179	0.00182	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—thyroid cancer	0.000179	0.00181	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—thyroid cancer	0.000179	0.00181	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—thyroid cancer	0.000179	0.00181	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—PPARG—thyroid cancer	0.000178	0.00148	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000174	0.00144	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000171	0.00173	CcSEcCtD
Bezafibrate—PPARG—Metabolism—MINPP1—thyroid cancer	0.000168	0.0014	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000168	0.00139	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Epirubicin—thyroid cancer	0.000166	0.00169	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—thyroid cancer	0.000166	0.00168	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—THRB—thyroid cancer	0.000165	0.00137	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—HPGD—thyroid cancer	0.000165	0.00137	CbGpPWpGaD
Bezafibrate—Abdominal pain—Doxorubicin—thyroid cancer	0.000165	0.00167	CcSEcCtD
Bezafibrate—PPARG—Gene Expression—TRIM33—thyroid cancer	0.000164	0.00136	CbGpPWpGaD
Bezafibrate—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.000161	0.00134	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000161	0.00134	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000161	0.00134	CbGpPWpGaD
Bezafibrate—Pruritus—Epirubicin—thyroid cancer	0.00016	0.00162	CcSEcCtD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000158	0.00131	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000156	0.0013	CbGpPWpGaD
Bezafibrate—Diarrhoea—Epirubicin—thyroid cancer	0.000155	0.00157	CcSEcCtD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000154	0.00128	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000154	0.00156	CcSEcCtD
Bezafibrate—PPARA—Metabolism—HPGD—thyroid cancer	0.000151	0.00126	CbGpPWpGaD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000151	0.00125	CbGpPWpGaD
Bezafibrate—Dizziness—Epirubicin—thyroid cancer	0.000149	0.00151	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	0.000149	0.00124	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CDK1—thyroid cancer	0.000148	0.00123	CbGpPWpGaD
Bezafibrate—Pruritus—Doxorubicin—thyroid cancer	0.000148	0.0015	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—TPR—thyroid cancer	0.000147	0.00122	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—RXRA—thyroid cancer	0.000146	0.00121	CbGpPWpGaD
Bezafibrate—Diarrhoea—Doxorubicin—thyroid cancer	0.000143	0.00145	CcSEcCtD
Bezafibrate—PPARG—Metabolism—NDUFA13—thyroid cancer	0.000143	0.00119	CbGpPWpGaD
Bezafibrate—Rash—Epirubicin—thyroid cancer	0.000142	0.00144	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—thyroid cancer	0.000142	0.00144	CcSEcCtD
Bezafibrate—Headache—Epirubicin—thyroid cancer	0.000142	0.00143	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000139	0.00115	CbGpPWpGaD
Bezafibrate—Dizziness—Doxorubicin—thyroid cancer	0.000138	0.0014	CcSEcCtD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000138	0.00115	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MEN1—thyroid cancer	0.000138	0.00114	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—RXRA—thyroid cancer	0.000137	0.00114	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CHST14—thyroid cancer	0.000134	0.00112	CbGpPWpGaD
Bezafibrate—Nausea—Epirubicin—thyroid cancer	0.000134	0.00136	CcSEcCtD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000134	0.00111	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MINPP1—thyroid cancer	0.000132	0.0011	CbGpPWpGaD
Bezafibrate—Rash—Doxorubicin—thyroid cancer	0.000132	0.00134	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—thyroid cancer	0.000132	0.00133	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—thyroid cancer	0.000131	0.00133	CcSEcCtD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000129	0.00107	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000129	0.00107	CbGpPWpGaD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000128	0.00107	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000125	0.00104	CbGpPWpGaD
Bezafibrate—Nausea—Doxorubicin—thyroid cancer	0.000124	0.00126	CcSEcCtD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000123	0.00102	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—PTEN—thyroid cancer	0.000122	0.00101	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—PPARG—thyroid cancer	0.000121	0.001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00012	0.000998	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—AKT1—thyroid cancer	0.000119	0.000986	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—THRB—thyroid cancer	0.000118	0.000984	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000117	0.000969	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000115	0.000952	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TPR—thyroid cancer	0.000114	0.000947	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—RXRA—thyroid cancer	0.000113	0.000939	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	0.000113	0.000935	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PRKAR1A—thyroid cancer	0.000112	0.000932	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—TPR—thyroid cancer	0.000112	0.000928	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00011	0.000915	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000109	0.000905	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HPGD—thyroid cancer	0.000108	0.0009	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000108	0.000897	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CDK1—thyroid cancer	0.000106	0.000881	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CHST14—thyroid cancer	0.000106	0.000879	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MEN1—thyroid cancer	0.000105	0.000872	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000105	0.000869	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.000869	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.000869	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000105	0.000869	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000104	0.00086	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.000855	CbGpPWpGaD
Bezafibrate—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	0.000102	0.000847	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000102	0.000844	CbGpPWpGaD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	9.98e-05	0.000829	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RXRA—thyroid cancer	9.84e-05	0.000818	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	9.67e-05	0.000804	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TPR—thyroid cancer	9.49e-05	0.000789	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PRKAR1A—thyroid cancer	9.34e-05	0.000776	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—RXRA—thyroid cancer	9.22e-05	0.000766	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—PPARG—thyroid cancer	9.21e-05	0.000765	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.17e-05	0.000762	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.79e-05	0.00073	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	8.75e-05	0.000727	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TPR—thyroid cancer	8.68e-05	0.000721	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PPARG—thyroid cancer	8.67e-05	0.00072	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PRKAR1A—thyroid cancer	8.54e-05	0.00071	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HPGD—thyroid cancer	8.53e-05	0.000709	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—SLC5A5—thyroid cancer	8.53e-05	0.000709	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.46e-05	0.000703	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—thyroid cancer	8.33e-05	0.000692	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MINPP1—thyroid cancer	8.3e-05	0.000689	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—TPR—thyroid cancer	8e-05	0.000665	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.99e-05	0.000664	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.83e-05	0.000651	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.74e-05	0.000643	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MINPP1—thyroid cancer	7.61e-05	0.000632	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MEN1—thyroid cancer	7.52e-05	0.000625	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—RXRA—thyroid cancer	7.17e-05	0.000596	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC5A5—thyroid cancer	7.11e-05	0.000591	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NDUFA13—thyroid cancer	7.05e-05	0.000586	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—RXRA—thyroid cancer	7.02e-05	0.000584	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.97e-05	0.000579	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.92e-05	0.000575	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	6.88e-05	0.000571	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.66e-05	0.000553	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CHST14—thyroid cancer	6.63e-05	0.000551	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.58e-05	0.000547	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC5A5—thyroid cancer	6.5e-05	0.00054	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NDUFA13—thyroid cancer	6.47e-05	0.000537	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TPR—thyroid cancer	6.22e-05	0.000517	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PRKAR1A—thyroid cancer	6.12e-05	0.000509	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.09e-05	0.000506	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CHST14—thyroid cancer	6.08e-05	0.000505	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—thyroid cancer	5.97e-05	0.000496	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—RXRA—thyroid cancer	5.97e-05	0.000496	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PPARG—thyroid cancer	5.82e-05	0.000484	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.81e-05	0.000483	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.56e-05	0.000462	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—RXRA—thyroid cancer	5.46e-05	0.000454	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HPGD—thyroid cancer	5.35e-05	0.000444	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.31e-05	0.000441	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—thyroid cancer	5.31e-05	0.000441	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—RXRA—thyroid cancer	5.03e-05	0.000418	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HPGD—thyroid cancer	4.9e-05	0.000407	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TPR—thyroid cancer	4.9e-05	0.000407	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	4.82e-05	0.000401	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC5A5—thyroid cancer	4.66e-05	0.000387	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—thyroid cancer	4.57e-05	0.000379	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—thyroid cancer	4.53e-05	0.000376	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—thyroid cancer	4.43e-05	0.000368	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.37e-05	0.000363	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.36e-05	0.000363	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.34e-05	0.00036	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.08e-05	0.000339	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.98e-05	0.00033	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—RXRA—thyroid cancer	3.91e-05	0.000325	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—thyroid cancer	3.88e-05	0.000323	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.81e-05	0.000316	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—thyroid cancer	3.8e-05	0.000316	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—thyroid cancer	3.77e-05	0.000313	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.67e-05	0.000305	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—thyroid cancer	3.56e-05	0.000296	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.47e-05	0.000288	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—thyroid cancer	3.45e-05	0.000287	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.44e-05	0.000286	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—thyroid cancer	3.43e-05	0.000285	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—thyroid cancer	3.27e-05	0.000272	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CHST14—thyroid cancer	3.26e-05	0.000271	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—thyroid cancer	3.1e-05	0.000258	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—RXRA—thyroid cancer	3.08e-05	0.000256	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TPR—thyroid cancer	3.07e-05	0.000255	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	3.02e-05	0.000251	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3e-05	0.000249	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—thyroid cancer	2.97e-05	0.000246	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TPR—thyroid cancer	2.82e-05	0.000234	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—thyroid cancer	2.78e-05	0.000231	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.77e-05	0.00023	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.74e-05	0.000228	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—thyroid cancer	2.71e-05	0.000225	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HPGD—thyroid cancer	2.63e-05	0.000219	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—thyroid cancer	2.59e-05	0.000215	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.51e-05	0.000209	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—thyroid cancer	2.46e-05	0.000204	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—thyroid cancer	2.37e-05	0.000197	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—thyroid cancer	2.3e-05	0.000191	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC5A5—thyroid cancer	2.3e-05	0.000191	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.15e-05	0.000179	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.11e-05	0.000175	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.97e-05	0.000164	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.95e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—thyroid cancer	1.94e-05	0.000162	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RXRA—thyroid cancer	1.93e-05	0.000161	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	0.000156	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—thyroid cancer	1.79e-05	0.000149	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RXRA—thyroid cancer	1.77e-05	0.000147	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—thyroid cancer	1.75e-05	0.000146	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.72e-05	0.000143	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—thyroid cancer	1.69e-05	0.000141	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.53e-05	0.000127	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TPR—thyroid cancer	1.51e-05	0.000126	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—thyroid cancer	1.49e-05	0.000124	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.49e-05	0.000124	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—thyroid cancer	1.36e-05	0.000113	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—thyroid cancer	1.26e-05	0.000104	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—thyroid cancer	1.22e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.13e-05	9.4e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—thyroid cancer	1.12e-05	9.29e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—thyroid cancer	9.77e-06	8.12e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—thyroid cancer	9.59e-06	7.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RXRA—thyroid cancer	9.5e-06	7.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—thyroid cancer	8.79e-06	7.31e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—thyroid cancer	8.37e-06	6.95e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—thyroid cancer	7.69e-06	6.39e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—thyroid cancer	7.67e-06	6.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—thyroid cancer	6e-06	4.99e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—thyroid cancer	4.82e-06	4.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.72e-06	3.92e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—thyroid cancer	4.42e-06	3.67e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—thyroid cancer	4.12e-06	3.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—thyroid cancer	2.37e-06	1.97e-05	CbGpPWpGaD
